Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Targeted Therapeutics for Transthyretin Cardiac Amyloidosis.

Literature DB >> 30664380

Targeted Therapeutics for Transthyretin Cardiac Amyloidosis.

Sanjiv J Shah¹.

Abstract

Entities: CellLine Chemical Disease Gene Mutation Species

Keywords: Editorials; amyloidosis; heart failure; precision medicine

Mesh：

Substances：

Year: 2019 PMID： 30664380 PMCID： PMC6438186 DOI： 10.1161/CIRCULATIONAHA.118.037593

Source DB: PubMed Journal: Circulation ISSN： 0009-7322 Impact factor: 29.690

× No keyword cloud information.

13 in total

Review 1. Individual response to treatment: is it a valid assumption?

Authors: Stephen Senn
Journal: BMJ Date: 2004-10-23

2. Identification of Transthyretin Cardiac Amyloidosis Using Serum Retinol-Binding Protein 4 and a Clinical Prediction Model.

Authors: Marios Arvanitis; Clarissa M Koch; Gloria G Chan; Celia Torres-Arancivia; Michael P LaValley; Daniel R Jacobson; John L Berk; Lawreen H Connors; Frederick L Ruberg
Journal: JAMA Cardiol Date: 2017-03-01 Impact factor: 14.676

3. Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis.

Authors: Candida Cristina Quarta; Scott D Solomon; Imran Uraizee; Jenna Kruger; Simone Longhi; Marinella Ferlito; Christian Gagliardi; Agnese Milandri; Claudio Rapezzi; Rodney H Falk
Journal: Circulation Date: 2014-02-21 Impact factor: 29.690

4. Cardiovascular precision medicine: hope or hype?

Authors: Geoffrey S Pitt
Journal: Eur Heart J Date: 2015-06-14 Impact factor: 29.983

5. Phenomapping for novel classification of heart failure with preserved ejection fraction.

Authors: Sanjiv J Shah; Daniel H Katz; Senthil Selvaraj; Michael A Burke; Clyde W Yancy; Mihai Gheorghiade; Robert O Bonow; Chiang-Ching Huang; Rahul C Deo
Journal: Circulation Date: 2014-11-14 Impact factor: 29.690

Review 6. Precision Medicine for Heart Failure with Preserved Ejection Fraction: An Overview.

Authors: Sanjiv J Shah
Journal: J Cardiovasc Transl Res Date: 2017-06-05 Impact factor: 4.132

7. Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis.

Authors: Scott D Solomon; David Adams; Arnt Kristen; Martha Grogan; Alejandra González-Duarte; Mathew S Maurer; Giampaolo Merlini; Thibaud Damy; Michel S Slama; Thomas H Brannagan; Angela Dispenzieri; John L Berk; Amil M Shah; Pushkal Garg; Akshay Vaishnaw; Verena Karsten; Jihong Chen; Jared Gollob; John Vest; Ole Suhr
Journal: Circulation Date: 2019-01-22 Impact factor: 29.690

8. Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis.

Authors: David Adams; Alejandra Gonzalez-Duarte; William D O'Riordan; Chih-Chao Yang; Mitsuharu Ueda; Arnt V Kristen; Ivailo Tournev; Hartmut H Schmidt; Teresa Coelho; John L Berk; Kon-Ping Lin; Giuseppe Vita; Shahram Attarian; Violaine Planté-Bordeneuve; Michelle M Mezei; Josep M Campistol; Juan Buades; Thomas H Brannagan; Byoung J Kim; Jeeyoung Oh; Yesim Parman; Yoshiki Sekijima; Philip N Hawkins; Scott D Solomon; Michael Polydefkis; Peter J Dyck; Pritesh J Gandhi; Sunita Goyal; Jihong Chen; Andrew L Strahs; Saraswathy V Nochur; Marianne T Sweetser; Pushkal P Garg; Akshay K Vaishnaw; Jared A Gollob; Ole B Suhr
Journal: N Engl J Med Date: 2018-07-05 Impact factor: 91.245

9. AG10 inhibits amyloidogenesis and cellular toxicity of the familial amyloid cardiomyopathy-associated V122I transthyretin.

Authors: Sravan C Penchala; Stephen Connelly; Yu Wang; Miki S Park; Lei Zhao; Aleksandra Baranczak; Irit Rappley; Hannes Vogel; Michaela Liedtke; Ronald M Witteles; Evan T Powers; Natàlia Reixach; William K Chan; Ian A Wilson; Jeffery W Kelly; Isabella A Graef; Mamoun M Alhamadsheh
Journal: Proc Natl Acad Sci U S A Date: 2013-05-28 Impact factor: 11.205